Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 70,000 shares at $30.51 ($2.2M) on 2022-04-14, disclosed to the SEC on 2022-04-14.
Open-market sale of $2.2M RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.80 | 28,000 | $890K | 40.3% |
| 2 | $31.94 | 14,000 | $447K | 20.2% |
| 3 | $31.96 | 14,000 | $447K | 20.2% |
| 4 | $30.51 | 14,000 | $427K | 19.3% |
| Total | $31.60 avg | 70,000 | $2.2M | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |